0.2303 0.00 (0.00%)
After hours: 5:30PM EDT
|Bid||0.2320 x 800|
|Ask||0.0000 x 1200|
|Day's Range||0.2300 - 0.2385|
|52 Week Range||0.2300 - 0.8650|
|Beta (3Y Monthly)||2.23|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
If you own shares in Actinium Pharmaceuticals, Inc. (NYSEMKT:ATNM) then it's worth thinking about how it contributes...
We're definitely into long term investing, but some companies are simply bad investments over any time frame. We don't...
The Zacks Analyst Blog Highlights: Alpine, Actinium, Molecular Templates, Tricida and Otonomy
Actinium (ATNM) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank 2 (Buy).
A look at the shareholders of Actinium Pharmaceuticals, Inc. (NYSEMKT:ATNM) can tell us which group is most powerful. Institutions often own shares in more established companies, while it's not unusualRead More...
If you're interested in Actinium Pharmaceuticals, Inc. (NYSEMKT:ATNM), then you might want to consider its beta (a measure of share price volatility) in order to understand how the stock could Read More...
Investors need to pay close attention to Actinium (ATNM) stock based on the movements in the options market lately.
A look at the shareholders of Actinium Pharmaceuticals Inc (NYSEMKT:ATNM) can tell us which group is most powerful. Generally speaking, as a company grows, institutions will increase their ownership. Conversely,Read More...